首页> 外文期刊>Journal of AIDS and HIV Research >Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) clinical trial activity on the African Continent: An analysis of HIV/AIDS trials registered on the Pan African Clinical Trials Registry
【24h】

Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) clinical trial activity on the African Continent: An analysis of HIV/AIDS trials registered on the Pan African Clinical Trials Registry

机译:人类免疫缺陷病毒/后天免疫缺陷综合症(HIV / AIDS)在非洲大陆的临床试验活动:对在泛非临床试验注册中心注册的HIV / AIDS试验的分析

获取原文
       

摘要

The human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemic is a major public health problem which poses a significant threat to livelihoods and social security in resource-poor countries due to the rapid spread of the infection amongst individuals at the prime of their productive age. Sub-Saharan Africa is the region most affected by HIV/AIDS with an estimated 24.7 million people living with HIV in 2014, and accounts for almost 70% of new infections globally. It is necessary for researchers, health workers, policy-makers and consumers to have information on planned and ongoing clinical trials. This will enable them to effectively assess interventions for the prevention and treatment of HIV/AIDS and its related conditions, as well planning appropriate future research. The aim of this study was to describe the current status of ongoing HIV clinical trials on the Pan African Clinical Trials Registry (PACTR) to inform African stakeholders of gaps in research, and potential areas of duplication. A cross-sectional analysis of trials currently registered on PACTR was conducted and excluded all trials that did not research HIV/AIDS interventions. Currently, there are 66 trials investigating HIV interventions registered with 28 looking at treatment. Co-morbid conditions are investigated in 20 trials. Forty-one of the trials are single-centered and being conducted across 14 countries. The remaining 52 trials are multicentered with sites in 14 African countries. At present, there is a growing number of planned or ongoing HIV/AIDS trials currently registered on www.pactr.org. This is encouraging as previous studies of published trials noted that not many were conducted in Africa. There has also been an increase in the number of African principal investigators, an indicator of regional capacity to conduct research.
机译:人体免疫机能丧失病毒/后天免疫机能丧失综合症(HIV / AIDS)大流行是一个重大的公共卫生问题,由于在感染初期,感染在个人之间迅速传播,对资源贫乏国家的生计和社会保障构成了重大威胁。他们的生产年龄。撒哈拉以南非洲是受艾滋病毒/艾滋病影响最严重的地区,2014年估计有2470万人感染艾滋病毒,占全球新感染病例的近70%。研究人员,卫生工作者,政策制定者和消费者必须了解计划中和正在进行的临床试验的信息。这将使他们能够有效地评估预防和治疗艾滋病毒/艾滋病及其相关状况的干预措施,并计划适当的未来研究。这项研究的目的是在泛非临床试验注册中心(PACTR)上描述正在进行的HIV临床试验的现状,以告知非洲利益相关者研究方面的差距以及潜在的重复领域。对目前在PACTR上注册的试验进行了横断面分析,排除了所有未研究HIV / AIDS干预措施的试验。目前,有66个试验调查了艾滋病干预措施,其中28个正在研究治疗方案。在20个试验中研究了共病条件。其中有41个试验是单中心试验,并且在14个国家/地区进行。其余52个试验在14个非洲国家/地区设有多个中心。目前,在www.pactr.org上注册的计划或正在进行的艾滋病毒/艾滋病试验越来越多。令人鼓舞的是,先前对已发表试验的研究表明,在非洲进行的活动不多。非洲主要调查人员的数量也有所增加,这是区域开展研究能力的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号